UPDATE 4-Not perfect, but saves lives, AstraZeneca says of COVID-19 vaccine
* To double supplies to 200 mln a month by April* To report U.S. trial results by end March* Forecasts 2021 core EPS of $4.75 to $5.00* Q4 sales beat expectations, profit in line (Recasts with CEO comments)By Pushkala Aripaka and Ludwig BurgerFeb 11...
Read more